4.7 Article

Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 69, 期 24, 页码 2913-2924

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2017.04.032

关键词

bleeding; mortality; myocardial infarction; volume-outcome relationship

资金

  1. Gilead Science
  2. Eli Lilly
  3. Sanofi
  4. Daiichi-Sankyo
  5. Janssen Pharmaceuticals
  6. Ferring Pharmaceuticals
  7. Myokardia
  8. AstraZeneca
  9. PriMed
  10. Boehringer Ingelheim
  11. Merck
  12. Actelion
  13. Amgen
  14. Novartis
  15. Quest Diagnostics
  16. Elsevier Publishers
  17. Boston Scientific
  18. Bristol-Myers Squibb
  19. Lily USA
  20. Pfizer
  21. Regeneron
  22. Gilead
  23. Medtronic

向作者/读者索取更多资源

BACKGROUND Professional guidelines have reduced the recommended minimum number to an average of 50 percutaneous coronary intervention (PCI) procedures performed annually by each operator. Operator volume patterns and associated outcomes since this change are unknown. OBJECTIVES The authors describe herein PCI operator procedure volumes; characteristics of low-, intermediate-, and high-volume operators; and the relationship between operator volume and clinical outcomes in a large, contemporary, nationwide sample. METHODS Using data from the National Cardiovascular Data Registry collected between July 1, 2009, and March 31, 2015, we examined operator annual PCI volume. We divided operators into low-(<50 PCIs per year), intermediate-(50 to 100 PCIs per year), and high-(>100 PCIs per year) volume groups, and determined the adjusted association between annual PCI volume and in-hospital outcomes, including mortality. RESULTS The median annual number of procedures performed per operator was 59;44% of operators performed <50 PCI procedures per year. Low-volume operators more frequently performed emergency and primary PCI procedures and practiced at hospitals with lower annual PCI volumes. Unadjusted in-hospital mortality was 1.86% for low-volume operators, 1.73% for intermediate-volume operators, and 1.48% for high-volume operators. The adjusted risk of in-hospital mortality was higher for PCI procedures performed by low-and intermediate-volume operators compared with those performed by high-volume operators (adjusted odds ratio: 1.16 for low versus high; adjusted odds ratio: 1.05 for intermediate vs. high volume) as was the risk for new dialysis post PCI. No volume relationship was observed for post-PCI bleeding. CONCLUSIONS Many PCI operators in the United States are performing fewer than the recommended number of PCI procedures annually. Although absolute risk differences are small and may be partially explained by unmeasured differences in case mix between operators, there remains an inverse relationship between PCI operator volume and in-hospital mortality that persisted in risk-adjusted analyses. (C) 2017 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据